These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1025553)

  • 1. [Determination of molecular weight of plasma substitute, gelatinol solution, by the viscosimetric method].
    Shlimak VM; Znamenskaia TV; Lazareva IV; Dmitrenko LV; Kallistov OV
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):56-8. PubMed ID: 1025553
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of the properties of gelatin on the quality of solution of the plasma substitute gelatinol].
    Chuprasov VK; Znamenskaia TV; Radkevich D
    Probl Gematol Pereliv Krovi; 1978 Jan; 23(1):53-5. PubMed ID: 628669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Physico-chemical characteristics of a new gelatin-type plasma expander].
    Scholz PM; Gruber UF
    Anaesthesist; 1971 May; 20(5):180-3. PubMed ID: 5104434
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemistry and physicochemical characterization of gelatin plasma substitutes.
    Schöne HH
    Bibl Haematol; 1969; 33():78-80. PubMed ID: 5377198
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation studies on a 4 per cent gelatin solution containing 1 per cent glycine for intravenous use.
    Gabr Y; Saleeb F; Osman M
    Arzneimittelforschung; 1967 May; 17(5):643-5. PubMed ID: 5631598
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood substitute gelatinol (experimental-clinical study)].
    Pushkar' LN; Gerasimova LI; Troitskiĭ VB
    Voen Med Zh; 1966 Jul; 7():14-6. PubMed ID: 5999449
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemical characterization of a plasma substitute preparation].
    Bonhard K
    Arzneimittelforschung; 1971 Nov; 21(11):1667-71. PubMed ID: 5172075
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of modern plasma expanders and blood substitutes.
    Rudowski WJ
    Br J Hosp Med; 1980; 23(4):389-99. PubMed ID: 6155961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Does gelatin as a blood substitute selectively depress plasma fibronectin? A clinical randomized study].
    Lackner F; Graninger W; Khosropour R
    Anaesthesist; 1985 Sep; 34(9):470-3. PubMed ID: 3909842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the effect of a plasma-substituting solution, gelatinol, on liver function. (Experimental study)].
    Khlebnikova IM; Znamenskaia TV
    Probl Gematol Pereliv Krovi; 1965 Aug; 10(8):50-3. PubMed ID: 5869006
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vascular filling by means of association of a balanced sodium solute and a modified fluid gelatin].
    Joder F; Laborit G
    Agressologie; 1972; 13(2):135-42. PubMed ID: 5078840
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physico-chemical characteristics of various plasma substitutes].
    Granath K; Strömberg R
    Minerva Anestesiol; 1968 Nov; 34(11):1300-11. PubMed ID: 5715827
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a modified, stroma-free hemoglobin solution as an oxygen-carrying plasma substitute.
    Kothe N; Eichentopf B; Bonhard K
    Surg Gynecol Obstet; 1985 Dec; 161(6):563-9. PubMed ID: 4071369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gelatin-derived plasma substitute Gelofusine causes low-molecular-weight proteinuria by decreasing tubular protein reabsorption.
    ten Dam MA; Branten AJ; Klasen IS; Wetzels JF
    J Crit Care; 2001 Sep; 16(3):115-20. PubMed ID: 11689768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [1st clinical trial of a new high-molecular-weight, gelatin-based plasma substitute].
    Scholz PM; Rittmann WW; Müller W; Leutenegger A; Gruber UF
    Schweiz Med Wochenschr; 1971 Jul; 101(27):987-94. PubMed ID: 5169067
    [No Abstract]   [Full Text] [Related]  

  • 16. [Biochemistry of plasma substitutes].
    Róka L
    Bibl Haematol; 1971; 37():266-78. PubMed ID: 5138912
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of gelatin plasma substitutes in blood based on detection of hydroxyproline derivatives.
    Liu T; Zhanga G; Li S; Wang Y; Ma G; Su Z
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Feb; 39(1):19-25. PubMed ID: 20586664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability (storability) of gelatin plasma substitute solutions with reference to military medical use.
    Schaller F; Roggen G
    Bibl Haematol; 1969; 33():587-97. PubMed ID: 5384025
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach.
    Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P
    Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of gelatinol in the erythrocytic transfusion media for extracorporeal circulation].
    Shulutko LS; Mikhnovich EP; Antonova EV
    Probl Gematol Pereliv Krovi; 1970 Sep; 15(9):57-9. PubMed ID: 5502493
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.